Kuros Biosciences Ltd (formerly Cytos Biotechnology Ltd) has named Virginia Jamieson as chief medical officer and a member of the executive board to help oversee the company’s business in tissue repair and regeneration. Dr Jamieson received her medical degree at Edinburgh University and obtained a postgraduate fellowship in anaesthesia from the Royal College of Surgeons in London. She previously worked for the company in both CMO and medical director capacities.
Kuros announced the appointment on 8 March 2016.
Copyright 2016 Evernow Publishing Ltd